Free tool
Stocks listed on Nasdaq GM
We cover 39 companies listed on Nasdaq GM. The median market value in the group is $3.19B. Across the group, the median move over the past trading day is −0.33%. 85% of the 39 with a 200-day average trade above it. Price change over the past year runs from −2.9% to +283.7% across the middle 80 percent of the group, with a median of +64.1%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
Table
39 of 701 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| PTGX | Protagonist Therapeutics, Inc. | $151.50 | +10.71% | +73.78% | +146.62% |
| NUVL | Nuvalent Inc | $123.96 | 0.00% | +22.93% | +62.83% |
| RYTM | Rhythm Pharmaceuticals, Inc. | $111.87 | +3.54% | +6.53% | +9.35% |
| LNTH | Lantheus Holdings, Inc. | $100.82 | −1.77% | +49.87% | +77.38% |
| ORKA | Oruka Therapeutics, Inc. | $99.44 | +9.94% | +251.75% | +555.07% |
| CNTA | Centessa Pharmaceuticals plc | $40.50 | 0.00% | +70.96% | +143.24% |
| TVTX | Travere Therapeutics, Inc. | $67.12 | +20.05% | +69.84% | +284.86% |
| XENE | Xenon Pharmaceuticals Inc. | $63.79 | −1.77% | +43.38% | +64.11% |
| RDNT | RadNet, Inc. | $76.47 | +20.96% | +7.78% | +7.27% |
| MIRM | Mirum Pharmaceuticals, Inc. | $98.51 | −12.22% | +26.18% | +31.96% |
| LGND | Ligand Pharmaceuticals Incorporated | $287.85 | −2.85% | +51.41% | +80.92% |
| CRSP | CRISPR Therapeutics AG | $59.23 | +24.56% | +10.15% | +10.65% |
| TNGX | Tango Therapeutics, Inc. | $25.47 | −4.43% | +185.22% | +269.13% |
| RLAY | Relay Therapeutics, Inc. | $19.46 | +6.40% | +137.90% | +445.10% |
| CPRX | Catalyst Pharmaceuticals Inc | $31.49 | 0.00% | +36.03% | +55.97% |
| IOVA | Iovance Biotherapeutics, Inc. | $8.08 | +71.91% | +220.63% | +233.88% |
| VCYT | Veracyte, Inc. Common Stock | $44.29 | −20.41% | +4.48% | +54.81% |
| GPCR | Structure Therapeutics Inc. | $49.35 | +3.05% | −27.55% | +159.74% |
| NAMS | NewAmsterdam Pharma Company N.V. | $27.40 | −2.07% | −22.16% | +11.97% |
| TMDX | TransMedics Group, Inc. | $92.22 | +20.88% | −24.83% | −21.43% |
| IRON | Disc Medicine, Inc. | $82.67 | +10.74% | +4.53% | +37.90% |
| ZLAB | Zai Lab Limited | $26.03 | +39.80% | +50.20% | −20.06% |
| NRIX | Nurix Therapeutics, Inc. | $26.71 | +10.60% | +47.90% | +179.69% |
| ATAI | AtaiBeckley Inc. | $7.39 | +2.92% | +90.96% | +61.71% |
| VERA | Vera Therapeutics, Inc. | $36.82 | +10.50% | −24.27% | +67.21% |
| CDNA | CareDx, Inc. | $50.96 | +42.55% | +166.25% | +283.45% |
| SUPN | Supernus Pharmaceuticals, Inc. | $44.88 | −5.97% | −9.28% | −0.42% |
| TRVI | Trevi Therapeutics, Inc. | $17.92 | −2.77% | +50.71% | +124.00% |
| RAPP | Rapport Therapeutics, Inc. | $52.50 | +25.12% | +86.77% | +250.70% |
| KOD | Kodiak Sciences Inc. | $39.33 | −2.38% | +51.15% | +321.09% |
| ATRC | AtriCure, Inc. | $48.17 | +21.18% | +22.66% | +29.14% |
| OCUL | Ocular Therapeutix, Inc. | $10.77 | +27.46% | −8.88% | −12.58% |
| HRMY | Harmony Biosciences Holdings, Inc. | $39.66 | +10.88% | +6.10% | +4.23% |
| URGN | UroGen Pharma Ltd. | $45.94 | +12.38% | +102.29% | +135.11% |
| PVLA | Palvella Therapeutics, Inc. | $154.33 | +8.04% | +53.90% | +173.39% |
| AUPH | Aurinia Pharmaceuticals Inc. | $16.54 | +10.56% | +7.75% | +36.58% |
| VCEL | Vericel Corporation | $42.44 | −9.14% | +19.18% | +18.25% |
| ADMA | ADMA Biologics, Inc. | $9.63 | +9.56% | −46.14% | −44.17% |
| XNCR | Xencor, Inc. Common Stock | $28.44 | +42.41% | +90.62% | +254.61% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.